NLRP3 and neoplasm: The result revealed the inhibition of the proliferation ability of both H446 and A549 by MCC950 (Additional file 1: Fig. S4), indicating that the suppression of NLRP3 may inhibit tumor growth and alleviate the progression of RILI.